Clinical Trials Browser

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Xerostomia

NCT01434394 2017-08-21

EAGLE

Phase 2/3 Completed

243 enrolled

Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01542931 2017-08-21

TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Phase 2/3 Completed

256 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00002533 2016-12-15

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Phase 2/3 Completed

CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Infections, Esthesioneuroblastoma, Olfactory

NCT01083550 2016-11-29

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

Phase 2/3 Completed

74 enrolled

Head & Neck

Thyroid Neoplasms

NCT01137097 2016-04-21

LSLNB

Phase 2/3 Completed

278 enrolled

Head & Neck

Thyroid Neoplasms

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase 2/3 Completed

10,838 enrolled

CNSGastrointestinalHead & NeckLymphoidThoracic

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT01596933 2015-03-10

NUTRIOM

Phase 2/3 Completed

91 enrolled

Head & Neck

Head and Neck Neoplasms, Weight Loss

NCT01335828 2013-01-25

SWETHY

Phase 2/3 Completed

125 enrolled

Head & Neck

Thyroid Nodule

NCT00778908 2012-08-21

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2/3 Completed

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01616316 2012-06-11

Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients

Phase 2/3 Completed

86 enrolled

Head & Neck

Thyroid Neoplasms

NCT00261703 2012-05-11

Docetaxel in Head and Neck Cancer

Phase 2/3 Completed

439 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00401323 2011-01-20

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 2/3 Completed

568 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

NCT00337532 2010-02-04

A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer

Phase 2/3 Completed

50 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00162708 2005-09-13

Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC

Phase 2/3 Completed

120 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms